Health Care·Health Care Equipment·$92.3B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.41 | N/A | +16.39% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.41 | N/A | +16.39% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management expressed confidence in the company's growth trajectory. They emphasized their commitment to enhancing product offerings.
Management highlighted strong performance in key product areas.
They noted ongoing investments in innovation and market expansion.
Boston Scientific's earnings report shows a positive surprise in EPS, which contributed to a 2.23% increase in stock price. The strong EPS performance indicates effective cost management and possibly robust demand for their products. However, the lack of revenue figures and guidance leaves some uncertainty about future performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
HALLIBURTON CO
Jul 23, 2018